Polygenic Risk Score Opportunities for Early Detection and Prevention Strategies in Endometrial Cancer
Affiliations
- PMID: 32624578
- DOI: 10.1038/s41416-020-0959-7
Abstract
Recent large-scale genetic studies, particularly genome-wide association studies (GWAS), have emphasised the importance of common genetic variation in endometrial cancer susceptibility. Although each of these variants only confer modest effects on endometrial cancer risk, together they are likely to explain a substantial amount of the familial relative risk of the disease. Therefore, methods to combine genetic risk variants, such as polygenic risk scores (PRS) have gained traction as an attractive method for individualised risk prediction and management. Here, we discuss the benefits of a PRS for endometrial cancer and considerations required for clinical implementation.
Similar articles
- Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?Br J Dermatol. 2019 Dec;181(6):1146-1155. doi: 10.1111/bjd.17917. Epub 2019 Jul 7.PMID: 30908599 Review.
- Polygenic Risk Scores in Coronary Artery Disease and Atrial Fibrillation.Heart Lung Circ. 2020 Apr;29(4):634-640. doi: 10.1016/j.hlc.2019.12.004. Epub 2019 Dec 27.PMID: 31974023 Review.
- Evaluating polygenic risk scores in assessing risk of nine solid and hematologic cancers in European descendants.Int J Cancer. 2020 Jun 25. doi: 10.1002/ijc.33176. Online ahead of print.PMID: 32588423
- Polygenic risk and hazard scores for Alzheimer's disease prediction.Ann Clin Transl Neurol. 2019 Feb 18;6(3):456-465. doi: 10.1002/acn3.716. eCollection 2019 Mar.PMID: 30911569 Free PMC article.
- Polygenic risk scores: from research tools to clinical instruments.Genome Med. 2020 May 18;12(1):44. doi: 10.1186/s13073-020-00742-5.PMID: 32423490 Free PMC article. Review.
.png)
No hay comentarios:
Publicar un comentario